Peptide Vaccines for Hypertension and Diabetes Mellitus

Hironori Nakagami1, Hiroshi Koriyama2, Ryuichi Morishita3

  • 1Division of Vascular Medicine and Epigenetics, Osaka University United Graduate School of Child Development, Osaka University, Kanazawa University and Hamamatsu University School of Medicine, Chiba University, Fukui University, 2-1 Yamada-oka, Suita, Osaka 565-0871, Japan. nakagami@cgt.med.osaka-u.ac.jp.

Vaccines
|September 8, 2015
PubMed

Insights

Therapeutic vaccines targeting endogenous hormones like angiotensin II for hypertension and DPP4 for diabetes are being developed. These novel vaccines aim to elicit protective antibodies without triggering harmful autoimmune responses, advancing vaccination concepts.

Area of Science:

  • Immunology
  • Vaccinology
  • Endocrinology

Background:

  • Traditional vaccines prevent infectious diseases; novel therapeutic vaccines target non-infectious conditions like Alzheimer's, cancer, hypertension, and diabetes.
  • Therapeutic cancer vaccines use cytotoxic T cells (CTLs) to target specific cancer antigens.
  • Existing therapeutic vaccine strategies face challenges with endogenous targets, risking autoimmune reactions.

Purpose of the Study:

  • To introduce a novel concept for therapeutic vaccines against hypertension and diabetes mellitus.
  • To describe a system for designing vaccines targeting endogenous hormones like angiotensin II (Ang II) and dipeptidyl peptidase 4 (DPP4).
  • To ensure vaccine-induced antibodies ameliorate disease without activating harmful CTL responses against self-antigens.

Main Methods:

  • Designing therapeutic vaccines targeting specific endogenous hormones (Ang II, DPP4).
  • Developing a system to elicit antibodies against target hormones.
  • Implementing strategies to avoid CTL activation against self-antigens (Ang II, DPP4).

Main Results:

  • Successfully designed therapeutic vaccines targeting Ang II for hypertension and DPP4 for diabetes.
  • The developed system aims to induce specific antibodies without causing autoimmune diseases.
  • The approach focuses on antibody-mediated therapeutic effects rather than cellular immunity.

Conclusions:

  • Therapeutic vaccines targeting endogenous hormones represent a new frontier in vaccinology.
  • This approach offers a potential strategy for treating hypertension and diabetes mellitus.
  • Careful vaccine design is crucial to prevent autoimmune complications when targeting endogenous molecules.

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.9K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
564
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
2.0K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Types of Hormones01:21

Types of Hormones

Hormones are classified into four main groups: steroids, eicosanoids, amino acid-based derivatives, and peptide hormones.
Steroids and eicosanoids fall under the category of lipid-soluble hormones. Steroids are derived from cholesterol and feature four interconnected carbon rings with variable side chains. Notable examples include estradiol from ovaries and testosterone from testes, exemplifying the critical roles of these lipid-soluble hormones in reproductive physiology. Eicosanoids, derived...
8.0K